Characteristic | MTX non-use n=84 | MTX use n=56 |
Age, years | 50.0±13.9 | 51.1±16.0 |
Female, n (%) | 54 (64) | 43 (77) |
Rheumatoid factor positive, n (%) | 66 (84)* | 49 (88) |
RA duration, years | 0.8±0.8 | 0.7±0.8 |
Prior DMARD use, n (%) | 27 (32) | 15 (27) |
Baseline corticosteroid use, n (%) | 35 (42) | 18 (32) |